so.moreau
Submits third-party assay reports on material purchased directly. Based in Recife.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
8
n=8
Annotations
0
n=0
Median purity submitted
99.57%
n=8
Suppliers covered
5
n=8
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041556 | TB-500 | QYB | QYB-2511-H6699 | Nordanalyt | 2026-Q1 | 99.70 | 6.58 | 94.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041348 | CJC-1295 with DAC | WWB | WWB-2508-V3100 | Janoshik | 2026-Q1 | 99.39 | 6.15 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041279 | Liraglutide | WWB | WWB-2509-J2476 | PeptideMeter | 2025-Q4 | 99.76 | 3.78 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018850 | Ipamorelin | QSC | QSC-2506-M9170 | Nordanalyt | 2025-Q3 | 99.58 | 3.96 | 90.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018814 | Kisspeptin-10 | QSC | QSC-2412-W8004 | Janoshik | 2025-Q1 | 99.57 | 5.47 | 97.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005310 | Semaglutide | SGN | SGN-2409-F8648 | Janoshik | 2024-Q4 | 97.98 | 4.36 | 90.2 | Laboratory-retained | 1 | MARGINAL |
| AX-2024-004328 | GHRP-6 | QSC | QSC-2405-W6407 | Janoshik | 2024-Q3 | 99.93 | 5.17 | 97.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-005537 | Semaglutide | BCH | BCH-2406-X8001 | Janoshik | 2024-Q3 | 99.37 | 2.78 | — | Supplier-supplied | 2 | MARGINAL |